Skip to main content

Advertisement

Log in

Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome

  • Brief report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract.

We have followed four patients with Bartter syndrome for a mean of 25.4 years (range 21.5–28.8 years) after diagnosis. All patients received non-steroidal anti-inflammatory drugs (NSAID). In all patients, various degrees of renal dysfunction were noted to be temporally associated with NSAID therapy. In two patients, renal dysfunction resolved after discontinuing NSAID therapy, while maintaining other chronic medications such as potassium-sparing diuretics. Renal dysfunction persisted after NSAID withdrawal in two patients. We report these cases as a warning that NSAID should be considered an important cause of either reversible or irreversible renal dysfunction in Bartter syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received December 2, 1997; received in revised form May 27, 1998; accepted May 29, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schachter, A., Arbus, G., Alexander, R. et al. Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome. Pediatr Nephrol 12, 775–777 (1998). https://doi.org/10.1007/s004670050545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670050545

Navigation